Pimecrolimus is a Calcineurin Inhibitor Immunosuppressant. The mechanism of action of pimecrolimus is as a Calcineurin Inhibitor. PIMOBENDAN is a small molecule drug with a maximum clinical trial phase of II. It is grouped under the following drug class(es): Calcineurin inhibitors. Its therapeutic use is listed as anti-inflammatories, anti-psoriatic agents and dermatologicals. The directory classifies it as a commercial API with a natural source/manufacturing origin. Other names for this substance include Elidel and Pacroma. Its PubChem CID is 6509979.
Pimecrolimus
| CAS No | 137071-32-0 |
|---|---|
| Molecular Formula | C43H68ClNO11 |
| Molecular Weight | 810.4 g/mol |
| Synonyms | (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(E)-1-[(1R,3R,4S)-4-chloro-3-methoxycyclohexyl]prop-1-en-2-yl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pimecrolimus is a Calcineurin Inhibitor Immunosuppressant. The mechanism of action of pimecrolimus is as a Calcineurin Inhibitor. PIMOBENDAN is a small molecule drug with a maximum clinical trial phase of II.
The listed CAS number is 137071-32-0.
The listed molecular formula is C43H68ClNO11.
The listed molecular weight is 810.4 g/mol.
(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(E)-1-[(1R,3R,4S)-4-chloro-3-methoxycyclohexyl]prop-1-en-2-yl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone.
The source lists Elidel and Pacroma.